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INTRODUCTION
Curcumin is the principle component of turmeric rhizome and exhibits 
various pharmacological activities, such as antiinflammatory, antioxidant, 
hepatoprotector, antibacterial and anticancer activity.1-3 Despite having 
excellent biological activity in vitro and in vivo, clinical application of 
this natural compound as a pharmaceutical agent is hampered because 
of its poor bioavailability after oral administration.4,5 The poor bioavail-
ability of curcumin can be ascribed to two reasons. First, curcumin 
exhibits an aqueous solubility of only 11 ng/mL,6 causing poor dissolution 
behavior in the gastrointestinal tract, by which only limited amount of 
dissolved molecules are available for absorption. E.g. in a publication of 
Wahlström et al. it was reported that 75% of the administered dose of 
curcumin was found in faeces indicating that curcumin was poorly 
dissolved in the gastrointestinal milieu.7 Second, once dissolved, curcumin 
is rapidly metabolized into curcumin glucuronate by UDP-glucuronos-
yltransferase.8
In Indonesian traditional medicine, a combination of turmeric and black 
pepper extract has been used in therapy.9 It was believed that additional 
of black pepper extract, which predominately contains piperine, enhances 
the efficacy of turmeric extract. Scientific research has meanwhile 
supported the rational basis of the enhanced efficacy of the combination: 
co-administration of piperine enhances curcumin’s bioavailability.10 
Another study showed that piperine is a UDP-glucuronosyltransferase 
inhibitor in both the small intestine and liver.11 Furthermore, piperine 
has been reported to increase bioavailability as it also acts as a P-glyco-
protein inhibitor in the gastrointestinal tract. Also a synergistic effect of 
piperine-curcumin has been found. An in vivo study in rats revealed 
that co-administration with piperine improved the antiiflammatory effect. 
In addition, piperine alone demonstrated antiinflammatory, analgesic, 
antineoplastic, axiolytic activity and stimulator of digestive enzyme.12
Similar to curcumin, piperine also exhibits a poor aqueous solubility. 
Therefore, in studying such combination the low aqueous solubility of 
both of these two compounds needs to be addressed. Solid dispersion 
technology is an often applied strategy to improve the dissolution 
behaviour of poorly soluble drugs.13 Therefore, in order to deal with the 
low aqueous solubility and to prepare a synergistic combination, which 
is expected to improve curcumin bioavailability in the pre-clinical study, 
we prepared microparticle based solid dispersion containing both 
curcumin and piperine. 
To evaluate this strategy, studying the in vitro dissolution behavior is 
being the first step in screening formulations. To be able to do so, an 
accurate and reliable analytical method is needed to determine both 
curcumin and piperine concentration. Furthermore, since dissolution 
experiments often involve large number of samples, rapid and economical 
analytical method is required.
Several analytical methods have been reported to quantify curcumin in 
the co-mixed curcumin-piperine. As in a methanolic solution, piperine 
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Objective: Curcumin and piperine exibit poor aqueous solubility and 
dissolution. Solid dispersion technology is a promising way to improve 
dissolution of lipophilic compounds. Therefore, to investigate the dissolution 
behavior, an accurate determination of curcumin and piperine concentra-
tions in a sample containing 0.5 wt-% SLS in sodium phosphate buffer as the 
dissolution medium was required. The goal of research was to investigate 
whether UV-Vis spectroscopy can be used to accurately determine 
curcumin and piperine concentrations in aqueous solutions. Method: 
Stock solutions (1 mg/mL) of curcumin and piperine were prepared in 
methanol. A series of solutions for calibration were prepared by mixing 
the stock solutions in various ratios after which they were diluted with 
dissolution medium (0.5%-wt sodium lauryl sulfate in 20 mM phosphate 
buffer; pH 6.0). Solutions of curcumin (2μg/mL) and piperine (1 μg/mL were 
subjected to overlay scan in a UV-VIS spectrophotometer in each λmax of 
430 and 335.5 nm for curcumin and piperine, respectively. The method 
was validated according ICH requirements, such as specificity, linearity, 
accuracy, precision, limit of detection and limit of quantification. Results: 
At a concentration range of 0.1 to 5μg/mL, calibration curves of curcumin 
and piperine showed linearity with R2 = 0.9980 and 0.9982, respectively. 
Precision and accuracy was confirmed by AOAC. Furthermore, LOD of 
both compounds was 0.23 μg/mL and LOQ of curcumin and piperine was 
0.72 and 0.69 μg/mL, respectively. Conclusion: UV-Vis spectroscopy can 
be used to accurately determine curcumin and piperine concentrations in 
dissolution samples obtained during screening the dissolution behavior of 
solid dispersions containing these compounds.
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and curcumin exhibit a λmax of 341 and 420 nm, respectively, it can be 
expected that both compounds will interfere each other during analysis 
by spectrophotometry method as the peaks may overlap. Therefore, the 
reported analytical methods are based on chromatography, i.e. Liquid 
Chromatography-Mass Spectrometry (LC-MS),14 High Performance 
Liquid Chromatography (HPLC),10,15,16 Ultra-Fast Liquid Chromatography17 
and High Performance Thin Layer Chromatography (HPTLC).18 
Although chromatographic method is suitable for selectively determine 
both curcumin and piperine concentrations, the reported methods 
require laborious sample extraction procedures by which it may poten-
tially affect negatively to the samples since curcumin degradation may 
occur due to inevitably light exposure.19 However, UV-Vis spectroscopic 
method has been reported to be suitable to determine concentration of 
curcumin/piperine/quercetin in an Ayurvedic polyherbal formulation.20 
Using a particular calculation involving the absorptivity of the tested 
compounds, the concentration of the compounds in a co-mixture could 
be accurately determined.21 In the current study, we aimed at validating 
a spectroscopic method for curcumin/piperine quantification from 
samples collected directly from the dissolution experiment where 
dissolution medium is present, which differs from the sample reported 
before.21 Therefore, the novelty of this study is in developing a spectro-
scopic based analytical method to estimate curcumin and piperine in 
dissolution medium using combinatorial equation.
MATERIALS AND METHODS
Materials
Curcumin as reference standard was purchased from Nacalai, Japan. 
C. longa standardized extract (97.56%) was supplied by PT Phytochemindo 
Reksa, Bogor, Indonesia. Piperine was isolated and purified as described 
before,22,23 after which it was further characterized based on piperine 
standard (Sigma Aldrich) using Thin Layer Chromatography method. 
Sodium dihydrogen phosphate and Sodium Lauryl Sulfate (SLS) were 
purchased from Merck, Darmstadt, Germany. Mili Q water was prepared 
in our laboratory. All solvents were of analytical grade and were purchased 
from Merck, Darmstadt, Germany. Dissolution medium consisting of 
0.5 wt-% SLS in 20 mM sodium phosphate buffer of pH 6.0 was prepared 
in our laboratory. 
Method
Determination of λmax
Solutions of curcumin (2 µg/mL) and piperine (1 µg/mL) prepared in 
dissolution medium was subjected to overlay scan in a UV spectropho-
tometer from 200-600 nm. It was confirmed that λmax for curcumin and 
piperine are of 430 and 335.5 nm, respectively. Additionally, as a control, 
solutions of curcumin and piperine in methanol at the same concentra-
tions were also scanned. The λmax for curcumin and piperine in methanol 
was 420 and 341 nm.
Preparation of calibration curve
Curcumin or piperine stock solutions were prepared in methanol at a 
concentration of 1.0 mg/mL. Series of solutions containing curcumin 
and piperine at various concentrations were prepared by spiking the 
dissolution medium with the stock solutions. The calibration curves 
were prepared at concentrations of 0.05 – 5 μg/mL for curcumin and 
piperine, respectively. Curcumin and piperine were simultaneously 
analyzed. Analyte concentrations were calculated based on combination 
calculation from the two λ measurements. Linearity of concentration 
and absorption and significance of the regressions were analyzed using 
Least Square Analysis method. The experiments were done in triplicate. 
Simultaneous equation for determination of curcumin/piperine
The equations (equation 1, 2) were derived based on the absorption of 
curcumin and piperine at the each maximum wavelength. Two wave-
lengths were selected (335 nm for curcumin and 430 nm for piperine) to 
calculate the concentrations based on equations 1 and 2. Furthermore, 
the absorptivity values E (1%, 1 cm) were determined for the piperine 
and curcumin at their maximum wavelength. 
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Cc: curcumin concentration
Cp: piperine concentration
A1: absorbance measured at λ 335.5 nm
A2: absorbance measured at λ 430.0 nm
Ac1: curcumin absorptivity at λ 335.5 nm in absorbance/ppm
Ac2: curcumin absorptivity at λ 430.0 nm in absorbance/ppm
Ap1: piperine absorptivity at λ 335.5 nm in absorbance/ppm
Ap2: piperine absorptivity at λ 430.0 nm in absorbance/ppm
Method Validation
The spectroscopic method for quantification of curcumin and piperine 
in the same solution was validated according Q2R1 ICH guidelines, 
which are linearity, accuracy and precision, Limit Of Detection (LOD) 
and Limit Of Quantification (LOQ).24 Linearity between concentrations 
and absorbance was assessed by analyzing the series concentration of 
calibration plot using Least Square Analysis. Correlation coefficient (r) 
of >0.99 was used to determine the linearity.25 For accuracy and precision 
studies, three different concentrations of curcumin and piperine in a 
mixture solution were prepared. Nine different samples were prepared 
at concentrations of 1, 2, 4 μg/mL curcumin and 0.5, 1, 2 μg/mL piperine 
in the dissolution medium. Accuracy was expressed as recovery value 
while precision was reflected by relative standard deviation (RSD) value. 
Inter-day precision and accuracy were determined at another 2 consecutive 
days. RSD were obtained by dividing the standard deviation with the 
mean value of obtained concentrations x 100%. Recovery was calculated 
by ratio of obtained concentration to the accordingly nominal concen-
tration × 100%. Linearity, accuracy and precision were judged according 
to AOAC requirements.25 LOD and LOQ were determined based on 
standard deviation of response and slope as described previously.26 LOD 
and LOQ were defined as 3.3 σ / S and 10σ / S, respectively, where σ is 
the standard error of intercept and S represents the mean of slopes as 
determined by the Least Square Analysis.
Application of the validated method 
The validated method was applied to quantify curcumin and piperine 
concentrations after dissolution of a solid dispersion formulation con-
taining both components. The solid dispersion were prepared by spray 
drying method using polyvinylpyrrolidon K30 (PVP K30) as carrier. The 
solid dispersion contained 30 wt-% curcuminoid, 1 wt-% piperine. In 
brief, curcumin, piperine and PVP K30 were dissolved in ethanol then 
spray dried using Büchi B-290 spray dryer equipped with a B-295 dehu-
midifier. Atomizing air was set at a flow 600 Ln/h. Inlet temperature and 
aspirator was set at 100°C and 100%, respectively. These setting resulted 
in an outlet temperature of 49-55°C.
The obtained spray dried powder were weighed accurately (100.00 mg) 
and then dissolved in 25.0 mL dissolution medium. A volume of 40 µL 
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was taken and diluted to 5.0 mL to achieve final concentrations of 
curcumin and piperine of 9.60 and 0.32 ug/mL. The absorbance of the 
diluted sample was measured at 335.5 and 430 nm for piperine and 
curcumin, respectively. The measurement was done in triplicate. The 
concentration of curcumin and piperine was calculated using equation 1 
and 2. 
RESULTS
Spectral Scanning
Spectral scanning of curcumin, piperine and the mixture of curcumin-
piperine solution are presented in Figure 1. In the methanolic solutions 
(Figure 1a), λmax of single compound of curcumin and piperine appeared 
to be 420.5 nm and 341 nm, respectively. Slight bathochromic shifts were 
observed when curcumin-piperine was co-mixed to 421 and 345 nm 
for curcumin and piperine, respectively. When medium dissolution 
was used to dissolve curcumin or piperine (Figure 1b), λmax of curcumin 
solution appeared to be bathochromic shifted to 430 with respect to λmax 
of its methanolic solution (420.5nm). Single piperine solution in medium 
dissolution appeared to exhibit a hypsochromic shift (335.5 nm) when 
compared to its methanolic solution (341.5 nm). A slight bathochromic 
shift was observed in a co-mixed curcumin-piperine in dissolution 
medium from its single piperine solution in dissolution medium 
(Figure 1b). From the scanning peaks data (Figure 1b) it is obvious 
that there was no interference of piperine peak at the λmax of curcumin. 
However, when the piperine concentration was determined using λmax 
of 335.5 nm, curcumin did interfere significantly. Our data showed that 
curcumin demonstrates significant absorbance at 0.05 at λmax of 535.5 
nm when the mixture was prepared at ratio curcumin: piperine 1:1 
(Figure 1a and 1b). Therefore, to minimize or to avoid the interference 
of other compound in the determination of piperine concentrations, 
calculation based on combinatorial equations as presented in equation 2 
has to be conducted. 
Method validation
The validation of the spectroscopic method for determination of 
curcumin-piperine in a dissolution sample followed the procedures as 
described by ICH.24
Linearity and range
The calibration curve obtained was evaluated by its correlation coefficient 
(r) and coefficient of determination (R2). To construct calibration curves, 
17 different concentrations of co-mixed of curcumin and piperine 
were prepared in dissolution medium. The concentrations ranged from 
0.005 – 5 µg/mL. The calibration curves of curcumin and piperine are 
depicted in Figure 2 and Figure 3. Linearity of curcumin or piperine 
was obtained from 10 different concentrations which ranged from 0.1 
to 5.0 µg/mL as indicted by r and R2 of 0.9989 and 0.9980, respectively, 
for curcumin and 0.9990 and 0.9982, respectively, for piperine solutions 
(Table 1).25 Moreover, regression analysis (Figure 2 and Figure 3) shows 
the regression was significant (p<0.05) which can be used as prediction 
model for the determination of curcumin and piperine concentration in 
the co-mixture solution. The LOD and LOQ were calculated based on 
the calibration curves of curcumin and piperine. The calculated LOD of 
curcumin and piperine was 0.23 µg/mL and the calculated LOQ values 
were 0.69 and 0.72 for piperine and curcumin, respectively. 
Figure 1: Spectral of curcumin, piperine and curcumin-piperine mixture 
prepared in methanol (a) and dissolution medium (b). Maximum wavelength 
shifts were observed when curcumin or piperine or the mixture of both were 
dissolved in dissolution medium.
Figure 2: Regression analysis of curcumin concentrations (ppm) vs  
absorbance at wavelength 1 (a) and 2 (b) with n = 3.
Figure 3: Regression analysis of piperine concentrations (ppm) vs  
absorbance at wavelength 1 (a) and 2 (b) with n = 3.
Table 1: Validation parameters for curcumin and piperine prepared in 
dissolution medium (n= 3).
Parameter Curcumin Piperine
λmax (nm) 430.0 335.5
Linear equation y = 0.02266x -0.00049 y = 0.076598x - 0.001014
Slope 0.139807 0.076598
R2 0.9980 0.9982
r 0.9989 0.9990
LOD (μg/mL) 0.23 0.23
LOQ (µg/mL) 0.72 0.69
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Table 2: Intraday and interday precision and accuracy of piperine (n=3).
Nominal concentration 
(µg/mL)
Intraday Interday
Found (µg/mL) Precision (%RSD) Accuracy 
(%recovery)
Found (µg/mL) Precision (% RSD) Accuracy (% recovery)
0.5 0.54 1.67 107.38 0.51 2.87 102.69
1.0 1.02 10.7 102.00 1.01 8.82 101.00
2.0 2.09 0.48 104.50 2.05 1.73 102.50
Table 3: Intraday and interday precision and accuracy of curcumin (n=3).
Nominal 
concentration 
(µg/mL)
Intraday Interday
Found (µg/mL) Precision (%RSD) Accuracy (%recovery) Found (µg/mL) Precision (% RSD) Accuracy (% recovery)
1.0 1.03 9.64 103.00 0.99 7.29  96.84
2.0 2.09 2.67 104.50 1.98 2.14  94.87
4.0 4.22 5.62 105.50 4.05 3.45  95.40
Precision and accuracy
Precision was evaluated at three different concentrations prepared in 
dissolution medium, which were 0.5, 1 and 2 µg/mL for piperine and 1, 2, 4 
µg/mL for curcumin. Precision and accuracy data are presented in Table 2 
and Table 3. Intra-day and inter-day precision study for curcumin and piper-
ine of the method shows RSD values between 0.48 – 10.70, which confirms 
reliability and stability of the method based on AOAC requirements.25 
Accuracy data as indicated by the recovery values shows recovery of 
94-107% which confirms the validity of the method according to the 
AOAC requirements.25
Application of the validated method
The validated method was applied to measure the concentration of 
curcumin and piperine dissolved in the dissolution medium. The sample 
dilution preparation was conducted as such mimicking the concentration 
found at the initial time sampling. Considering the dose of 500 mg 
curcuminoids and 5 mg of piperine in a tablet as conducted in a clinical 
trial10 and of at least 5% analyte should be released in 1000 mL of dissolution 
medium during earlier sampling, it is required to be able to measure 
concentrations of 25 µg/mL curcumin and 0.25 µg/mL of piperine 
accurately. Using this validated spectroscopic method, curcumin 
concentration was found to be 10.11 ± 0.09 µg/mL with RSD value of 
0.89% while the piperine concentration was found to be 0.33 ± 0.06 µg/mL 
with RSD value of 18.18%. Taking the expected concentrations of 25 
and 0.25 µg/mL for curcumin and piperine during initial time sampling 
and the found concentrations of 10.11 ± 0.09 µg/mL (curcumin) and 
0.33 ± 0.06 µg/mL (piperine), it can be concluded that this validated 
spectroscopic method is sensitive enough to simultaneously quantify 
curcumin and piperine in the dissolution sample. Although we prepared 
a slightly higher concentration of piperine in the dissolution sample 
(around 0.32 µg/mL) than the expected concentration appears in 
dissolution media (0.25 µg/mL), we were still able to confirm the sensitivity 
of the method based on the found LOD (0.23 µg/mL). In the sample, the 
RSD of piperine was quite high, which was 18.18%. The RSD value of 
piperine was high due to the very low piperine concentration approaching 
at detection level of the method (0.23 µg/mL).
DISCUSSION
The aim of this study was to develop and validate a spectroscopic method 
to determine curcumin and piperine in dissolution samples. As a BCS II 
drug, dissolution behavior of curcumin and piperine is being the most 
important predictive parameter for the bioavailability.27 In screening of a 
formula candidate, dissolution behavior of a drug is the most useful 
parameters, which it may end up with large number of dissolution samples 
and those need quick analysis to allow rapid selection of formula for bio-
availability evaluation.
Analytical method validation objective is to demonstrate suitability and 
reliability of an analytical procedure for its intended purpose.28 This study 
validated the spectroscopic method to quantify curcumin and piperine 
in the dissolution medium. The dissolution medium contained 0.5 wt-% 
SLS in 20 mM sodium phosphate buffer of pH 6.0. Sodium phosphate 
buffer at pH 6.0 was used to confirm curcumin stability during dissolution 
study, since curcumin was found to be stable at pH 6.0.6 SLS was added 
in the dissolution medium to attain sink condition.29 Although chro-
matographic methods are found in many publications for accurately 
determine curcumin-piperine, SLS and sodium phosphate buffer in the 
dissolution media may cause poor peak separation in chromatographic 
method. Collier et al. reported that SLS in the dissolution media inter-
feres the chromatographic separation of levothyroxine as indicated by a 
dramatic decrease in plate counts after number of samples injection into 
the HPLC column, and that resulted a high variability in drug content in 
the dissolution samples.30 Recently, Setyaningsih et al. found that SLS and 
sodium phosphate buffer cause peak tailing of curcuminoids resulting 
poor peak separation.31 The interference caused by SLS and sodium 
phophate buffer leads to jeopardize accurate estimation of curcumin in 
dissolution samples.
Sample preparation is required to obtain satisfactory chromatographic 
peaks separations. However, extensive sample preparation, which may 
involve multiple clean up steps followed by extraction procedures, might 
raise stability concerns of curcumin. A report from Tonnesen and Karlson 
suggests that when using buffers and ethyl acetate for extraction, polym-
erization of curcumin can occur at the interface of the two phases.19
Although spectroscopic method has been acknowledged as not selective; 
there is no ability of the method to determine curcumin from curcumi-
noids mixture, as these curcuminoids appears to be overlaping in UV 
spectra at the same wavelength,30 the method are still useful to determined 
curcumin concentration in dissolution study. Despite the selectivity 
problem, the spectrophotometric method offers simplicity, rapidity and 
reliability.32,33 Being the major component in curcuminoids mixture, 
curcumin concentration in samples can be determined as total curcumi-
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noids which are present in the dosage forms or polyherbal samples.20 
Taken all together, spectrophotometry remains valuable method to de-
termine curcumin in the dissolution samples. Furthermore, using com-
binatorial equation involving absorptivity molar and absorbance of cur-
cumin and piperine (equation 1 and 2), this developed method are able 
to reliably determine curcumin in co-existence with piperine
This proposed spectroscopic method confirms linearity, accuracy and 
precision of the method as required by AOAC. The LOD of piperine and 
curcumin was 0.23 μg/mL and LOQ were 0.69 and 0.72 for piperine and 
curcumin, respectively. As comparison, when methanol was used to prepare 
samples, Aneja et.al found LOD of 0.71 μg/mL and 0.45 μg/mL and LOQ 
of 2.1 μg/mL and 1.49 μg/mL for piperine and curcumin, respectively,21 
which indicates that this validated method of curcumin/piperine quanti-
fication in dissolution medium is more sensitive compared to the previous 
report.
CONCLUSION
The UV-Vis spectroscopy method is accurate, precise and reliable to be 
used for the quantification of curcumin and piperine in dissolution 
medium composed of 0.5 wt-% SLS in 20 mM sodium phosphate buffer 
of pH 6.0 where curcumin and piperine are co-present. Moreover, the 
LOD shows to be sensitive. Thus validation confirmed that the method 
is applicable for the determination of curcumin or piperine during 
dissolution studies. 
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